https://pressroom.prlog.org/Oncotelic/ About Oncotelic Inc - Company is focusing on developing antisense therapeutic against TGF-beta against pancreatic cancer. Treatment has been shown to more than double survival. We are continuing developing the drug- OT-101/Trabedersen for the treatment of pancreatic cancer. https://www.prlog.org/12630011-oncotelic-and-autotelic-inc-to-present-data-on-ot-101-program-at-2017-american-association-for-cancer-research-annual-meeting.html Improved Overall Survival in Advanced Pancreatic Cancer treated with Trabedersen (OT-101)Thu, 30 Mar 2017 10:55:02 GMT https://www.prlog.org/12583773-oncotelic-and-autotelic-inc-present-clinical-data-at-2017-gi-cancer-symposium-to-support-il-8-positive-association-with-survival.html Improved Overall Survival in Advanced Pancreatic Cancer treated with Trabedersen (OT-101)Wed, 18 Jan 2017 08:50:39 GMT